Amgen is facing false claims suit, firm discloses following SB Clinical Labs settlement.
Executive Summary
AMGEN NAMED IN FALSE CLAIMS ACT WHISTLEBLOWER SUIT, the company revealed in a Feb. 26 Securities & Exchange Commission filing. "Amgen has been advised that it and certain purchasers of its products have been named as defendants in a civil lawsuit initiated by a former employee of Amgen," the company said. The suit was brought in Philadelphia federal court but is under seal pending Department of Justice review.